Physician profile
Alexander Lo
NPI 1821617853
$961.44
in general payments reported to CMS, 2019-2025
10 companies · $429 in 2025
The $429 reported for 2025 was more than what 77% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.30 · 2024: $491 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $223.65 | 2024-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $221.34 | 2024-2025 | Ozempic |
| Phadia US INC. | $206.28 | 2024 | Immunocap |
| Teleflex LLC | $158.63 | 2025 | Urolift |
| Pfizer INC. | $38.32 | 2024 | |
| Organon LLC | $26.73 | 2025 | Nexplanon |
| Averitas Pharma INC. | $22.78 | 2024 | Qutenza |
| Smith+Nephew, INC. | $22.41 | 2025 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $21.95 | 2023 | Delstrigo, Pifeltro, Dificid |
| Acadia Pharmaceuticals INC | $19.35 | 2023 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.